Anti-TGF-ß1 aptamer enhances therapeutic effect of tyrosine kinase inhibitor, gefitinib, on non-small cell lung cancer in xenograft model.

Takahashi, Masaki; Hashimoto, Yoshifumi; Nakamura, Yoshikazu

Takahashi, Masaki; Hashimoto, Yoshifumi; Nakamura, Yoshikazu.

Afiliación

Takahashi M; Project Division of RNA Medical Science, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
Hashimoto Y; Project Division of RNA Medical Science, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
Nakamura Y; Project Division of RNA Medical Science, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.

Mol Ther Nucleic Acids ; 29: 969-978, 2022 Sep 13.

Article en En | MEDLINE | ID: mdl-36189081

Palabras clave

TGF-ß1; aptamer; gefitinib; isoform specific; non-small cell lung cancer; oligonucleotides; therapies and applications

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google